Point72 Asia (Singapore)’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,004
Closed -$255K 1346
2024
Q1
$255K Buy
+5,004
New +$167K 0.07% 335

Other funds holding NGNE

Point72 Asia (Singapore)'s NGNE Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Neurogene (NGNE) in Q2 2024, closing a stake of 5,004 shares — an estimated $255K sold.

Point72 Asia (Singapore) first reported a position in NGNE in Q1 2024 and held it in 1 quarter. The position peaked at $255K in Q1 2024. 66 funds tracked by Wall St. Rank hold NGNE as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Neurogene position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 5,004 Neurogene shares in Q2 2024, an estimated $255K.
  • Point72 Asia (Singapore) first reported a position in Neurogene in Q1 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Neurogene position peaked at $255K in Q1 2024.
  • 66 funds tracked by Wall St. Rank held Neurogene as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.